Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

IMPORTANCE: Guidelines currently recommend ticagrelor over clopidogrel for patients with acute coronary syndrome (ACS) based on randomized clinical trial data in which ticagrelor reduced major adverse coronary events (MACE) vs clopidogrel but increased bleeding and dyspnea. OBJECTIVE: To compare the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Intern Med
Main Authors: Turgeon, Ricky D., Koshman, Sheri L., Youngson, Erik, Har, Bryan, Wilton, Stephen B., James, Matthew T., Graham, Michelle M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6990835/
https://ncbi.nlm.nih.gov/pubmed/31930361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2019.6447
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados